Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven Gary DuBois, M.D.

Concepts (469)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neuroblastoma522022118011.490 Why?
3-Iodobenzylguanidine3020221066.920 Why?
Bone Neoplasms39202225775.910 Why?
Gene Amplification7202010882.240 Why?
Antineoplastic Combined Chemotherapy Protocols322022112532.170 Why?
Neoplasms432022202862.040 Why?
Osteosarcoma1120228881.820 Why?
Adrenal Gland Neoplasms720227291.770 Why?
Neoplasm Recurrence, Local27202287991.740 Why?
Radiopharmaceuticals18202227031.740 Why?
Antineoplastic Agents332022137701.730 Why?
Iodine Radioisotopes11202110431.610 Why?
Neuroectodermal Tumors, Primitive, Peripheral32021401.570 Why?
Child1322022736231.560 Why?
Bone Marrow Neoplasms220201081.490 Why?
Child, Preschool912022411291.460 Why?
Neoplasms, Second Primary9202110111.370 Why?
Vincristine9202110391.300 Why?
Medical Oncology12202120521.260 Why?
Salvage Therapy7202112931.220 Why?
Infant672022341571.200 Why?
Pyrimidines9202229571.190 Why?
Receptor, trkA420201591.120 Why?
Adolescent1012022850931.070 Why?
Camptothecin320165491.000 Why?
Paraganglioma220221470.990 Why?
SEER Program13202015630.960 Why?
Sarcoma8202218440.960 Why?
Drug Resistance, Neoplasm11202152350.960 Why?
Central Nervous System Neoplasms420218550.930 Why?
Glomus Tumor12022580.920 Why?
Prognosis382022290310.900 Why?
Clinical Trials, Phase I as Topic320203310.870 Why?
Soft Tissue Neoplasms4201813230.860 Why?
Indenes12021560.860 Why?
Polycythemia120211140.850 Why?
Norepinephrine Plasma Membrane Transport Proteins32015680.830 Why?
Maximum Tolerated Dose920219230.820 Why?
Minors12020420.820 Why?
Pathology, Molecular220213400.810 Why?
Clinical Trials as Topic11202180240.810 Why?
Clinical Trials, Phase II as Topic320206210.800 Why?
Neoplasms, Unknown Primary120201010.780 Why?
Calmodulin-Binding Proteins220112600.760 Why?
Radiation-Sensitizing Agents520183850.750 Why?
Gene Fusion220193720.750 Why?
Humans17920227060920.730 Why?
Off-Label Use120201850.690 Why?
Radionuclide Imaging5202220380.680 Why?
Amyloid Precursor Protein Secretases120226070.670 Why?
Industry120203670.670 Why?
Age Factors162020189400.670 Why?
Young Adult542022560110.660 Why?
Azepines220183410.650 Why?
Ganglioneuroma12017580.650 Why?
Oncogene Proteins, Fusion9202215810.630 Why?
Kaplan-Meier Estimate14201868140.630 Why?
Thoracic Neoplasms220192600.630 Why?
Pyrazoles5202219570.620 Why?
Hydroxamic Acids320155070.610 Why?
Oncogene Proteins420157750.600 Why?
Benzazepines120183330.600 Why?
Wilms Tumor320153410.600 Why?
Male10220223511810.590 Why?
Research Support as Topic220207270.590 Why?
Pyrroles4202112070.590 Why?
Carcinoma, Neuroendocrine120193210.590 Why?
Vesicular Monoamine Transport Proteins12015310.590 Why?
Basic Helix-Loop-Helix Transcription Factors1202111520.570 Why?
Disease-Free Survival13202170530.560 Why?
Female10420223762490.560 Why?
Survival Rate152021133640.550 Why?
Neoplasms, Radiation-Induced120195690.550 Why?
Bone Marrow5202029350.540 Why?
Molecular Targeted Therapy10202228890.520 Why?
Indoles4202118980.520 Why?
Radiotherapy3201916240.510 Why?
Neoplastic Cells, Circulating220118630.500 Why?
Dysostoses1201290.490 Why?
Neoplasm Staging142022112050.480 Why?
Ifosfamide420212240.480 Why?
Pelvic Neoplasms120142440.470 Why?
Neoplasms, Multiple Primary120176280.470 Why?
Infant, Newborn222022243140.470 Why?
Adult6220222118170.470 Why?
Dacarbazine120165900.460 Why?
Gene Dosage1201712720.460 Why?
Annexin A5120121200.460 Why?
Treatment Outcome302021617480.460 Why?
Protein Kinase Inhibitors8202253670.450 Why?
RNA-Binding Proteins2201119030.440 Why?
Nuclear Proteins7202259730.430 Why?
Histones3201825780.420 Why?
Neoplasm Metastasis9201951940.420 Why?
Follow-Up Studies222021393350.410 Why?
Gastrointestinal Stromal Tumors320216640.390 Why?
Neovascularization, Pathologic3201427230.390 Why?
RNA-Binding Protein EWS320212070.390 Why?
Retrospective Studies322022706990.380 Why?
Topotecan220211380.380 Why?
Hematopoietic Stem Cell Transplantation5202251010.370 Why?
Cohort Studies182020395380.370 Why?
Mortality1202027640.360 Why?
Sirolimus4201715720.350 Why?
Introns1201110200.350 Why?
Proportional Hazards Models72017124080.350 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma5202014510.340 Why?
Cyclophosphamide4202121890.340 Why?
Kidney Neoplasms6201740500.330 Why?
Translocation, Genetic3202114320.320 Why?
Biomedical Research2202032750.320 Why?
Cytarabine120096870.320 Why?
Loss of Heterozygosity320196920.310 Why?
Tissue Distribution5202124420.310 Why?
Thyroid Neoplasms1201922060.300 Why?
United States Food and Drug Administration6202217710.300 Why?
Chromosome Aberrations4201918120.300 Why?
Fibrosarcoma220183440.300 Why?
Carcinoma4202223300.300 Why?
Databases, Factual4201877690.300 Why?
Neoplasm Proteins2202138830.300 Why?
Pregnancy Complications, Neoplastic120082690.300 Why?
Pheochromocytoma220223400.290 Why?
Etoposide420176300.290 Why?
Drug Administration Schedule6202051140.280 Why?
Drug Dosage Calculations320201160.280 Why?
United States212022669380.280 Why?
Lymphocyte Count120078180.270 Why?
Neoadjuvant Therapy4201925760.270 Why?
Combined Modality Therapy12202089060.270 Why?
Gene Expression Regulation, Neoplastic5202087230.270 Why?
Gastrointestinal Neoplasms320219590.260 Why?
Ferritins220195640.260 Why?
Gene Frequency1201137110.260 Why?
Doxorubicin5202122250.260 Why?
Angiogenesis Inhibitors2201420680.250 Why?
Neutropenia320178700.240 Why?
Flow Cytometry3201161840.240 Why?
Adenocarcinoma1202064380.230 Why?
Radiometry420168090.230 Why?
Normetanephrine12021280.230 Why?
Receptor Protein-Tyrosine Kinases3202216290.230 Why?
Drug Approval320208980.230 Why?
Time Factors112020412450.220 Why?
Leukemia, Lymphoid120023800.220 Why?
Whole-Body Irradiation320164560.220 Why?
Granuloma, Plasma Cell12022890.220 Why?
Lymph Nodes1201334160.210 Why?
Proteins3202161710.210 Why?
Neoplasms, Muscle Tissue12021870.210 Why?
Genomics7202252060.210 Why?
Dose-Response Relationship, Drug72021113680.210 Why?
Chromogranins120211790.210 Why?
L-Lactate Dehydrogenase220144450.210 Why?
Histone Deacetylase Inhibitors320188050.210 Why?
Registries2202079910.200 Why?
Head and Neck Neoplasms1201426630.200 Why?
Tumor Suppressor Protein p533201929810.200 Why?
Survival Analysis72020105850.200 Why?
Drug Monitoring220189340.200 Why?
Lymphoma2201919070.200 Why?
Chi-Square Distribution2202035920.200 Why?
Protein-Tyrosine Kinases3202224620.200 Why?
Diketopiperazines12019190.200 Why?
Radiotherapy Dosage4202029060.190 Why?
Indole Alkaloids12019300.190 Why?
Prenylation12019390.190 Why?
DNA Glycosylases120201350.190 Why?
Alleles1201171260.190 Why?
Neoplasms, Connective and Soft Tissue12019230.190 Why?
Cell Line, Tumor52022171060.190 Why?
Research Subjects120212370.190 Why?
Government120201470.190 Why?
Mutation92020291710.180 Why?
Fluorodeoxyglucose F183202219890.180 Why?
Adrenal Glands120215420.180 Why?
High-Throughput Nucleotide Sequencing3202236990.180 Why?
Risk Factors122020700410.180 Why?
Receptor, Notch1120225160.180 Why?
Nomograms120202280.180 Why?
In Situ Hybridization, Fluorescence3202126650.180 Why?
Genomic Structural Variation12018630.180 Why?
Brain Neoplasms6202086990.170 Why?
Cell Cycle Proteins3202234980.170 Why?
Drug Industry320219070.170 Why?
Germ-Line Mutation4202017250.170 Why?
Ribonuclease III120202700.170 Why?
Nephroma, Mesoblastic12017250.170 Why?
Calcitonin120193490.170 Why?
Healthcare Disparities1201329800.170 Why?
Academies and Institutes120202970.170 Why?
Endothelial Cells1201133850.170 Why?
Carbazoles120192560.170 Why?
Jumonji Domain-Containing Histone Demethylases120181850.160 Why?
Legislation, Drug120202340.160 Why?
Prospective Studies92022505490.160 Why?
DEAD-box RNA Helicases120203500.160 Why?
Cancer Care Facilities120204180.160 Why?
Antibodies, Monoclonal4202298220.160 Why?
Stem Cells1201135930.160 Why?
Technetium Tc 99m Medronate120171380.160 Why?
Administration, Oral4202039580.160 Why?
Blood Pressure1201384970.160 Why?
Logistic Models32019136010.160 Why?
Leukemia2201614910.160 Why?
Retreatment120186280.150 Why?
Gene Expression Profiling3201995460.150 Why?
National Institutes of Health (U.S.)120207520.150 Why?
Survivors3201621320.150 Why?
Genetic Heterogeneity120207510.150 Why?
Tongue Neoplasms120171780.150 Why?
Disease Progression62021132650.150 Why?
Leukemia, Myeloid120197330.150 Why?
Health Services Accessibility1201349860.150 Why?
Tablets120161520.150 Why?
Glucuronosyltransferase120161230.150 Why?
Antibiotics, Antineoplastic220177750.150 Why?
Glioma2202232360.150 Why?
Blood Sedimentation120162360.140 Why?
Signal Transduction22021239780.140 Why?
Pediatrics6202135510.140 Why?
Vascular Endothelial Growth Factor A1200734790.140 Why?
Syndrome1202131700.140 Why?
Recurrence6201682580.140 Why?
Pelvic Bones120172680.140 Why?
Risk3201998010.140 Why?
Rhabdoid Tumor120172110.140 Why?
Drug Discovery2202010740.140 Why?
Antibodies, Bispecific120161420.140 Why?
Histone Deacetylases220187550.140 Why?
Models, Biological3202199240.140 Why?
Neoplasm, Residual120209830.140 Why?
Tumor Burden4201919360.140 Why?
Dose-Response Relationship, Radiation420209280.130 Why?
Molecular Diagnostic Techniques120195970.130 Why?
Acetylation2201511270.130 Why?
Lymphatic Metastasis2201329820.130 Why?
Transplantation, Autologous4202120710.130 Why?
Polymorphism, Single Nucleotide32019155270.130 Why?
Pyridazines120152170.130 Why?
Mitosis1201912440.130 Why?
Cyclin-Dependent Kinase 4120175210.120 Why?
Receptor, IGF Type 1120163980.120 Why?
Purines120176020.120 Why?
Aminopyridines120175290.120 Why?
Paraffin Embedding120143180.120 Why?
Cytoskeletal Proteins1201914350.120 Why?
Nifedipine120132220.120 Why?
Biological Products120228460.120 Why?
Genetic Engineering120199530.120 Why?
Incidence62020205140.120 Why?
Growth Plate120142710.120 Why?
Killer Cells, Natural1200222030.120 Why?
Lung Neoplasms32021123950.120 Why?
Immunologic Factors1202215620.110 Why?
International Cooperation2202114540.110 Why?
Microtubule-Associated Proteins1201711000.110 Why?
Powders12011910.110 Why?
Pyrrolidinones120121260.110 Why?
Proto-Oncogene Proteins2202246890.110 Why?
Serine Endopeptidases1201711290.110 Why?
Extremities120178660.110 Why?
Dexmedetomidine120152840.110 Why?
Genome1202017190.110 Why?
Models, Animal1201822100.110 Why?
Radiosurgery1202013180.110 Why?
Randomized Controlled Trials as Topic2202194520.110 Why?
Melanoma2201954850.110 Why?
Piperidines1201915770.110 Why?
Multivariate Analysis32014125140.100 Why?
Age Distribution1201729090.100 Why?
Middle Aged1720212150440.100 Why?
Telangiectasis12010760.100 Why?
Genetic Association Studies1202027090.100 Why?
Microphthalmia-Associated Transcription Factor120122610.100 Why?
Neuroectodermal Tumors, Primitive120111440.100 Why?
Forecasting1201929420.090 Why?
Proteinuria120126150.090 Why?
Li-Fraumeni Syndrome120101180.090 Why?
NF-kappa B1201825630.090 Why?
Dactinomycin120093410.090 Why?
Antigens, CD2201141970.090 Why?
Risk Assessment42020234860.090 Why?
Fibromatosis, Aggressive120091130.090 Why?
Vasodilator Agents1201310130.090 Why?
Biopsy1202067700.090 Why?
Magnetic Resonance Imaging42021339890.090 Why?
Pilot Projects2202080180.080 Why?
DNA Damage1201824860.080 Why?
Lipoma120103360.080 Why?
Aged, 80 and over62021586560.080 Why?
Proto-Oncogene Proteins c-met120126080.080 Why?
Gene Expression2201880630.080 Why?
Epigenesis, Genetic1202134380.080 Why?
Liposarcoma120103100.080 Why?
Proto-Oncogene Proteins c-mdm2120103860.080 Why?
Intensive Care Units, Pediatric120149620.080 Why?
Hypnotics and Sedatives1201511060.080 Why?
Cisplatin2201616700.080 Why?
Statistics, Nonparametric3202029560.080 Why?
Stem Cell Transplantation2201616530.080 Why?
Aged1120211622440.080 Why?
Quinolines120127390.080 Why?
Boston1202094030.080 Why?
Busulfan220212710.080 Why?
Escherichia coli1201944210.080 Why?
Linear Models1201760020.080 Why?
Tomography, X-Ray Computed42022202760.080 Why?
Mass Spectrometry1201423020.080 Why?
Immunotherapy1202240840.080 Why?
Melphalan220213820.070 Why?
Upper Extremity120105390.070 Why?
Boronic Acids1201010000.070 Why?
Drug Utilization1201212270.070 Why?
Leukemia, Myeloid, Acute2201732570.070 Why?
Immunohistochemistry32015118980.070 Why?
Models, Statistical1202050230.070 Why?
Amputation120107960.070 Why?
Anti-Infective Agents120129260.070 Why?
Carcinoma, Small Cell120074320.070 Why?
Asparaginase220202170.070 Why?
Chemotherapy, Adjuvant1201335140.070 Why?
Acute Disease2201371950.070 Why?
Research Design1202058070.070 Why?
Genotype22016129570.070 Why?
Pyrazines1201012650.060 Why?
Granulocyte Colony-Stimulating Factor120076380.060 Why?
Receptors, Progesterone1200811080.060 Why?
Positron-Emission Tomography2202261110.060 Why?
Cell Adhesion Molecules1201016930.060 Why?
Drug Evaluation, Preclinical2202014060.060 Why?
Hospitals, Pediatric1201217670.060 Why?
Plasma Cell Granuloma, Pulmonary12021150.060 Why?
Mice, Nude3201839080.060 Why?
Phenotype22020162650.060 Why?
Hearing Loss120096930.060 Why?
Case-Control Studies22011218270.060 Why?
Carcinoma, Squamous Cell1201739740.060 Why?
Animals820201702740.050 Why?
Academic Medical Centers1201227820.050 Why?
Infusions, Intravenous2201623110.050 Why?
Desmoplastic Small Round Cell Tumor12020270.050 Why?
European Union120211670.050 Why?
Tanzania2201511440.050 Why?
Hospital Mortality1201451020.050 Why?
Receptors, Estrogen1200821180.050 Why?
Clinical Protocols2201614680.050 Why?
Mitoxantrone120201550.050 Why?
Genetic Predisposition to Disease42021173210.050 Why?
Cytochrome P-450 CYP3A120201120.050 Why?
Bone and Bones1201125560.050 Why?
Therapies, Investigational120201040.050 Why?
Drug and Narcotic Control120201480.050 Why?
Membrane Proteins1201781000.050 Why?
Sequence Analysis, RNA2201820220.050 Why?
Socioeconomic Factors1201376950.050 Why?
Predictive Value of Tests12015152810.050 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120228990.050 Why?
Xenograft Model Antitumor Assays2201837580.040 Why?
Carrier Proteins1201251800.040 Why?
Dexamethasone2202019260.040 Why?
Health Status Disparities1201017150.040 Why?
Arabinonucleosides12017350.040 Why?
Heart1201142540.040 Why?
Adenine Nucleotides120171320.040 Why?
Radiography1200969870.040 Why?
Annual Reports as Topic12017360.040 Why?
Isotretinoin120181050.040 Why?
Radiation Dosage2202020450.040 Why?
Receptor, trkB120181310.040 Why?
Drug Labeling120202620.040 Why?
Rare Diseases120215110.040 Why?
TOR Serine-Threonine Kinases2201621130.040 Why?
Proto-Oncogene Proteins c-ets120173080.040 Why?
Thrombocytopenia1200411320.040 Why?
Gene Expression Regulation12015124600.040 Why?
Chromosomes, Human, Pair 19120173740.040 Why?
Chromosomes, Human, Pair 15120173750.040 Why?
Germany120188270.040 Why?
Fatal Outcome2201218900.040 Why?
Congresses as Topic120207840.040 Why?
Benzothiazoles120162490.030 Why?
Morpholines120185740.030 Why?
Confidence Intervals1202029850.030 Why?
Stomatitis120162660.030 Why?
Genetic Testing2201732930.030 Why?
African Americans1201052080.030 Why?
Polyethylene Glycols1202012040.030 Why?
Hypertension1201381200.030 Why?
Disease Susceptibility1202017980.030 Why?
Europe1202033530.030 Why?
Proto-Oncogene Proteins c-myc1199910080.030 Why?
Radiation Injuries1202012310.030 Why?
Organ Specificity1201820770.030 Why?
Metanephrine12012260.030 Why?
Single-Blind Method1201616000.030 Why?
Sarcoma, Alveolar Soft Part12012400.030 Why?
Blotting, Western2201155120.030 Why?
Compassionate Use Trials12012450.030 Why?
Phenylurea Compounds120165610.030 Why?
Sarcoma, Clear Cell12012640.030 Why?
fms-Like Tyrosine Kinase 3120164670.030 Why?
Glucocorticoids1202121090.030 Why?
Consensus1202126450.030 Why?
Tumor Stem Cell Assay120111210.030 Why?
Minnesota120123790.030 Why?
Chemistry, Pharmaceutical120122920.030 Why?
Treatment Failure1201726810.030 Why?
Conscious Sedation120155010.030 Why?
Reverse Transcriptase Polymerase Chain Reaction2201149770.030 Why?
Cephalosporins120122190.030 Why?
California1201514060.030 Why?
Drug Utilization Review120122580.030 Why?
Epigenomics120167930.030 Why?
Regression Analysis1202065130.030 Why?
Protein Kinases1201816780.020 Why?
DNA Copy Number Variations1201818600.020 Why?
Gamma Rays120113330.020 Why?
Inappropriate Prescribing120121950.020 Why?
Multicenter Studies as Topic1201415200.020 Why?
Monte Carlo Method1201512940.020 Why?
Software2201543470.020 Why?
Age of Onset1201633920.020 Why?
Methotrexate1201617090.020 Why?
DNA Repair Enzymes120113670.020 Why?
Vancomycin120125090.020 Why?
DNA Repair1201820420.020 Why?
Mice42018807230.020 Why?
Luminescent Proteins120118870.020 Why?
Health Policy1202026170.020 Why?
Pregnancy12008266770.020 Why?
Myelodysplastic Syndromes1201612400.020 Why?
Membrane Glycoproteins1201838310.020 Why?
Sequence Analysis, DNA1201849490.020 Why?
Cross-Sectional Studies22017228070.020 Why?
Protease Inhibitors120108290.020 Why?
Computer Simulation1202060290.020 Why?
Repressor Proteins1201730600.020 Why?
Diagnosis, Differential12021133560.020 Why?
Hematologic Neoplasms1201616650.020 Why?
Radiography, Thoracic1201213350.020 Why?
Neoplasms, Experimental1201113580.020 Why?
Microscopy, Electron, Transmission120077560.020 Why?
Family Health1201013080.020 Why?
Prescription Drugs120126060.020 Why?
Societies, Medical1201736510.020 Why?
Pancreatic Neoplasms1202151160.020 Why?
Staining and Labeling1200811600.020 Why?
Rhabdomyosarcoma120073800.020 Why?
Contrast Media1201752470.020 Why?
Forkhead Transcription Factors1201115900.020 Why?
Developing Countries1201526570.020 Why?
Early Detection of Cancer1201728090.010 Why?
Parents1201631600.010 Why?
Transplantation, Heterologous1201124290.010 Why?
Tumor Cells, Cultured1201166590.010 Why?
Imaging, Three-Dimensional1201639950.010 Why?
Transcription Factors12022119670.010 Why?
Pedigree1201047190.010 Why?
Inflammation1202198950.010 Why?
HEK293 Cells1201143320.010 Why?
RNA, Messenger12016133470.010 Why?
Cell Survival1201161810.010 Why?
Comorbidity12014106060.010 Why?
Carcinoma, Renal Cell1201229660.010 Why?
Cell Proliferation12011108420.010 Why?
Apoptosis12011101270.010 Why?
Quality of Life12012114460.010 Why?
Breast Neoplasms12017196990.010 Why?
DuBois's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (469)
Explore
_
Co-Authors (116)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.